XXII 22nd Century Group, Inc. Stock Quote

XXII [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.26	Insider Own	2.80%	Shs Outstand	182.00M	Perf Week	-12.60%
Market Cap	361.11M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	-0.34%	Shs Float	162.40M	Perf Month	-6.08%
Income	-43.80M	PEG	-	EPS next Q	-0.06	Inst Own	21.40%	Short Float	8.94%	Perf Quarter	-6.08%
Sales	39.30M	P/S	9.19	EPS this Y	-47.00%	Inst Trans	-1.67%	Short Ratio	6.28	Perf Half Y	-26.72%
Book/sh	0.55	P/B	3.09	EPS next Y	4.50%	ROA	-50.30%	Target Price	5.90	Perf Year	-52.11%
Cash/sh	0.12	P/C	13.73	EPS next 5Y	-	ROE	-57.90%	52W Range	1.42 - 4.05	Perf YTD	-44.98%
Dividend	-	P/FCF	-	EPS past 5Y	-7.60%	ROI	-42.60%	52W High	-58.02%	Beta	1.62
Dividend %	-	Quick Ratio	1.90	Sales past 5Y	20.30%	Gross Margin	5.60%	52W Low	19.72%	ATR	0.14
Employees	76	Current Ratio	2.50	Sales Q/Q	72.60%	Oper. Margin	-89.60%	RSI (14)	41.03	Volatility	7.13% 7.99%
Optionable	Yes	Debt/Eq	0.07	EPS Q/Q	-134.30%	Profit Margin	-	Rel Volume	1.37	Prev Close	1.74
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 09 BMO	Payout	-	Avg Volume	2.31M	Price	1.70
Recom	2.00	SMA20	-7.87%	SMA50	-11.63%	SMA200	-23.78%	Volume	3,154,634	Change	-2.30%

Jul-21-22

Initiated

Alliance Global Partners

Buy

Jun-15-22

Initiated

Craig Hallum

Buy

Mar-08-22

Initiated

ROTH Capital

Buy

Jul-23-21

Initiated

Cowen

Outperform

Oct-16-17

Reiterated

Chardan Capital Markets

Buy

$3.50 → $11.50

Aug-11-16

Reiterated

Chardan Capital Markets

Buy

$4.50 → $3.50

Aug-09-22 06:00AM	22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022 GlobeNewswire -5.12%
Jul-27-22 07:00AM	22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022 GlobeNewswire
Jul-21-22 10:00AM	22nd Century Group (Nasdaq: XXII) Strengthens Balance Sheet to Accelerate the Expansion of VLN Launch GlobeNewswire
09:00AM	22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules GlobeNewswire
Jun-22-22 09:25AM	22nd Century Group (Nasdaq: XXII) Supports Federal Proposal to Require Less Nicotine in All U.S. Cigarettes GlobeNewswire +20.25%
Jun-16-22 08:30AM	22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO GlobeNewswire -6.49%
May-27-22 09:25AM	22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings GlobeNewswire
May-23-22 09:25AM	22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business GlobeNewswire
May-18-22 04:30PM	22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform GlobeNewswire -7.33%
May-13-22 02:08PM	Clarence's 22nd Century Group acquires Las Vegas-based hemp/cannabis company American City Business Journals +7.01%
09:16AM	22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company GlobeNewswire
May-08-22 08:32AM	22nd Century Group, Inc. (NASDAQ:XXII) Just Reported And Analysts Have Been Lifting Their Price Targets Simply Wall St.
May-07-22 08:31AM	Is 22nd Century Group (NASDAQ:XXII) In A Good Position To Invest In Growth? Simply Wall St.
May-05-22 06:00AM	22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022 GlobeNewswire -5.73%
Apr-29-22 09:30AM	22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDAs Proposed Ban on Menthol Cigarettes GlobeNewswire
Apr-28-22 09:30AM	22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders GlobeNewswire
Apr-27-22 09:25AM	22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partners Virtual Spring Consumer Cannabis Conference GlobeNewswire
Apr-14-22 08:00AM	22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022 GlobeNewswire -5.38%
Apr-13-22 08:00AM	First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland GlobeNewswire
Apr-11-22 09:25AM	22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer GlobeNewswire
Mar-28-22 09:28AM	FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That Helps You Smoke Less Obtains Illinois Tobacco Product Listing GlobeNewswire
Mar-09-22 09:30AM	22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15 GlobeNewswire
Mar-01-22 06:00AM	22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021 GlobeNewswire
Feb-28-22 10:05AM	22nd Century Group Announces South Korea as First VLN® International Market GlobeNewswire
Feb-25-22 09:51AM	22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in Combustible Cigarettes GlobeNewswire
Feb-23-22 08:00AM	22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation GlobeNewswire
Feb-22-22 11:49AM	Those who invested in 22nd Century Group (NASDAQ:XXII) five years ago are up 131% Simply Wall St.
Feb-10-22 11:30AM	22nd Century Secures USDA Organic Certification for Needle Rock Farms GlobeNewswire
Feb-03-22 09:20AM	22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022 GlobeNewswire
Feb-01-22 12:30PM	22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes GlobeNewswire
Jan-27-22 05:38PM	Campbell Wealth Management Buys Schwab U.S. Large-Cap ETF, iShares Core U.S. ... GuruFocus.com -8.29%
Jan-26-22 11:00AM	22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale GlobeNewswire
Jan-21-22 08:00AM	22nd Century Group Appoints James A. Mish to Its Board of Directors GlobeNewswire
Jan-18-22 08:00AM	22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less GlobeNewswire
Jan-03-22 02:23PM	22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022 GlobeNewswire
Dec-28-21 08:42AM	Do Options Traders Know Something About 22nd Century (XXII) Stock We Don't? Zacks -7.25%
Dec-23-21 10:59PM	FDA Authorizes Marketing of 22nd Century Groups VLN® as a Modified Risk Tobacco Product GlobeNewswire +38.64%
02:31PM	XXII Stock Alert: Why Is 22nd Century Group Soaring Higher Today? InvestorPlace
11:47AM	FDA Authorizes Marketing of 22nd Century Groups VLN® as a Modified Risk Tobacco Product GlobeNewswire
08:04AM	22nd Century Shares Pop On FDA Marketing Authorization Investing.com
Dec-16-21 12:02PM	Why Austin is the hottest housing market of 2021 Yahoo Finance Video
Dec-14-21 04:05PM	Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group PR Newswire
04:05PM	Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group CNW Group
Dec-10-21 09:20AM	22nd Century Ready to Provide Full Commercial Support to New Zealands Plan to Reduce Nicotine Content of All Cigarettes GlobeNewswire
Nov-22-21 12:00PM	Is 22nd Century Group (NASDAQ:XXII) Using Too Much Debt? Simply Wall St.
Nov-19-21 08:30AM	22nd Century Group Announces CFO Transition GlobeNewswire
Nov-15-21 09:20AM	22nd Century Group Applauds Califf Nomination as FDA Commissioner GlobeNewswire +8.05%
Nov-11-21 09:20AM	22nd Century to Participate in Cowen and Roth Capital Investor Conferences in November 2021 GlobeNewswire
Nov-04-21 06:00AM	22nd Century Group Reports Business Highlights and Financial Results for the Third Quarter 2021 GlobeNewswire
Oct-28-21 03:06PM	Earnings Preview: 22nd Century Group (XXII) Q3 Earnings Expected to Decline Zacks
Oct-20-21 09:20AM	22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results GlobeNewswire
Oct-13-21 04:01PM	22nd Century Group VP of Regulatory Science to Participate in FDLI Panel in Response to Recent FDA Action on Comprehensive Plan and Reduced Nicotine Mandate GlobeNewswire
Oct-04-21 08:38AM	Implied Volatility Surging for 22nd Century (XXII) Stock Options Zacks
Oct-01-21 09:20AM	22nd Century to Participate in the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7 GlobeNewswire +5.07%
Sep-27-21 04:30PM	22nd Century to Participate in September and October 2021 Investor Conferences GlobeNewswire
Sep-14-21 12:51PM	Top Pharmaceutical Stocks for Q4 2021 Investopedia
Aug-30-21 09:20AM	22nd Century Group Enters Global Specialty Hops Market GlobeNewswire -12.85%
Aug-19-21 09:20AM	22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors GlobeNewswire
Aug-17-21 09:20AM	22nd Century to Present at SNN Network Investor Conference on August 19 GlobeNewswire -5.35%
Aug-16-21 09:20AM	22nd Century Group to Ring Nasdaq Closing Bell Today, August 16 GlobeNewswire -11.91%
08:30AM	Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021 ACCESSWIRE
Aug-08-21 12:30AM	22nd Century Group (XXII) Q2 2021 Earnings Call Transcript Motley Fool
Aug-07-21 07:30AM	3 Under-the-Radar Cannabis Stocks Investors Need to Know Motley Fool
Aug-05-21 04:15PM	22nd Century Group to Begin Trading on Nasdaq on August 16, 2021 GlobeNewswire +17.73%
07:55AM	22nd Century Group (XXII) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:00AM	22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021 GlobeNewswire
Jul-29-21 03:05PM	Will 22nd Century Group (XXII) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-22-21 09:25AM	22nd Century Group Secures New Contract Manufacturing Agreements, Expands Distribution Network and Manufacturing Capabilities Ahead of VLN® Launch GlobeNewswire
Jul-19-21 09:25AM	22nd Century Group to Host Webcast to Provide Business Update and Discuss Second Quarter 2021 Results GlobeNewswire
Jul-14-21 09:25AM	22nd Century Group Adds Strategic Partnerships With Sawatch Agriculture and Folium Botanical for Next-Generation Commercial Hemp/Cannabis Plant Breeding and Commercial Scale-Up GlobeNewswire
Jul-01-21 09:17AM	22nd Century Announces Restructuring of Panacea Investment, Expansion of Cannabis Franchise Capabilities GlobeNewswire -9.07%
Jun-29-21 11:06AM	Is 22nd Century Group a Buy? Motley Fool
Jun-25-21 09:25AM	22nd Century Group Provides Business Update from CEO Detailing Company Progress Over Past Year and Future Initiatives GlobeNewswire
Jun-10-21 07:00AM	Four Cannabis Stocks for the Summer of 2021 GlobeNewswire
Jun-09-21 04:30PM	22nd Century Announces Closing of $40 Million Common Stock Registered Direct Offering GlobeNewswire
01:35PM	Reduced Nicotine Tobacco and Cannabinoid Innovator 22nd Century Group to Be Added to Russell 2000®, Russell 3000®, and Russell Global Indexes GlobeNewswire
Jun-07-21 05:51PM	Why 22nd Century Group, HEXO, and Canopy Growth Stocks All Popped Today Motley Fool +13.17%
10:42AM	22nd Century Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise GlobeNewswire
09:25AM	22nd Century Announces $40 Million Common Stock Registered Direct Offering GlobeNewswire
Jun-03-21 12:38PM	22nd Century Group: Disrupting The Plant-Based Markets With Improved Genetics Benzinga
May-24-21 09:06AM	22nd Century to Participate in May and June 2021 Investor Conferences GlobeNewswire
May-18-21 10:06AM	22nd Century VP of Regulatory Science to Present on Health Disparities Caused by Cigarette Addiction at FDLI Annual Conference GlobeNewswire +13.18%
May-07-21 10:31AM	22nd Century Group (XXII) Q1 2021 Earnings Call Transcript Motley Fool
May-06-21 10:45AM	22nd Century Group (XXII) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:00AM	22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021 GlobeNewswire
May-05-21 10:06AM	22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production GlobeNewswire -6.93%
May-04-21 09:20AM	22nd Century Group and KeyGene Extend and Expand Plant Research Partnership GlobeNewswire
Apr-30-21 11:05AM	22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles Still on the Table GlobeNewswire
06:40AM	An Upcoming FDA Decision on Nicotine Could Send This Stock Soaring Motley Fool
Apr-29-21 06:50AM	Congresswoman Gwen Moore Adds Voice to Groundswell of Support for Reducing Nicotine in Cigarettes, Encourages HHS Secretary Becerra to Take Action to Save Lives and End Health Disparities GlobeNewswire -15.66%
Apr-26-21 10:06AM	22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies GlobeNewswire
Apr-22-21 10:35AM	22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results GlobeNewswire
Apr-21-21 10:35AM	22nd Century Group Issues Annual Letter to Shareholders GlobeNewswire +6.95%
Apr-20-21 04:00PM	22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S. GlobeNewswire +5.35%
Apr-15-21 05:56PM	22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan GlobeNewswire
Apr-08-21 10:06AM	22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee GlobeNewswire +9.47%
Apr-06-21 07:12AM	3 Best Emerging Marijuana Stocks to Buy in April Motley Fool
Apr-01-21 10:06AM	Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd Century GlobeNewswire +5.78%
Mar-23-21 09:30AM	22nd Century Group (NYSEMKT:XXII) Is In A Good Position To Deliver On Growth Plans Simply Wall St. -8.26%
Mar-19-21 01:00PM	Becerra Confirmation Boosts 22nd Centurys Position to Disrupt Tobacco Industry GlobeNewswire +5.61%

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FRANZINO JOHN	Chief Administrative Officer	Jun 14	Sale	1.69	20,324	34,443	405,574	Jun 16 04:18 PM
SULLIVAN NORA B	Director	May 16	Option Exercise	1.39	100,000	139,000	748,707	May 18 04:39 PM
ZERCHER MICHAEL	President and COO	Dec 14	Sale	2.16	23,147	50,037	1,064,985	Dec 16 04:28 PM
MISH JAMES A	Chief Executive Officer	Sep 30	Buy	2.88	20,000	57,600	668,475	Sep 30 04:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience